Immunomodulatory cytokines suppress epithelial nitric oxide production in inflammatory bowel disease by acting on mononuclear cells

Free Radical Biology and Medicine

Volumn 39, Issue 12, 2005, Pages 1560-1569

  Linehan, John D ^a,b   Kolios, George ^c   Valatas, Vassilis ^c   Robertson, Duncan A F ^b   Westwick, John ^a,d  

^a University of Bath   (United Kingdom)

^b ROYAL UNITED HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CRETE   (Greece)

^d NOVARTIS HORSHAM RESEARCH CENTRE   (United Kingdom)

Author keywords

Colonic epithelial cells; Free radicals; Inflammatory bowel disease; Interleukin 10; Nitric oxide

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; NITRIC OXIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL STRAIN HT29; COCULTURE; COLON; COLON BIOPSY; COLON MUCOSA; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG RESPONSE; ENTERITIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; INFLAMMATION; MALE; MEDIATOR; MIXED CELL CULTURE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STIMULATION; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COCULTURE TECHNIQUES; COLITIS, ULCERATIVE; COLON; CULTURE MEDIA, CONDITIONED; CYTOKINES; EPITHELIAL CELLS; FEMALE; HT29 CELLS; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-10; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II;

EID: 27844520171     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2005.07.019     Document Type: Article

References (46)

1. G. Kolios, N. Rooney, C.T. Murphy, D.A.F. Robertson, and J. Westwick Expression of inducible nitric oxide synthase activity in human colon epithelial cells: modulation by T-lymphocyte derived cytokines Gut 43 1998 56 63
2. G.A. West, T. Matsuura, A.D. Levine, J.S. Klein, and C. Fiocchi Interleukin 4 in inflammatory bowel disease and mucosal immune reactivity Gastroenterology 110 1996 1683 1695
3. T. Kucharzik, N. Lugering, H. Weigelt, M. Adolf, W. Domschke, and R. Stoll Immunoregulatory properties of IL-13 in patients with inflammatory bowel disease: comparison with IL-4 and IL-10 Clin. Exp. Immunol. 104 1996 483 490
4. M.R. de Waal, J. Abrams, B. Bennett, C.G. Figdor, and J.E. de Vries Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes J. Exp. Med. 174 1991 1209 1220
5. R. Kuhn, J. Lohler, D. Rennick, K. Rajewsky, and W. Muller Interleukin-10-deficient mice develop chronic enterocolitis Cell 75 1993 263 274
6. O.H. Nielsen, T. Koppen, N. Rudiger, T. Horn, J. Eriksen, and I. Kirman Involvement of interleukin-4 and -10 in inflammatory bowel disease Dig. Dis. Sci. 41 1996 1786 1793
7. B.J. Whittle Nitric oxide in gastrointestinal physiology and pathology L.R. Johnson Physiology of the gastrointestinal tract 1994 Raven Press New York 269 294
8. T. Kucharzik, R. Stoll, N. Lugering, and W. Domschke Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBD) Clin. Exp. Immunol. 100 1995 452 456
9. J.O. Lindsay, C.J. Ciesielski, T. Scheinin, H.J. Hodgson, and F.M. Brennan The prevention and treatment of murine colitis using gene therapy with adenoviral vectors encoding IL-10 J. Immunol. 166 2001 7625 7633
10. L. Steidler, W. Hans, L. Schotte, S. Neirynck, F. Obermeier, W. Falk, W. Fiers, and E. Remaut Treatment of murine colitis by Lactococcus lactis secreting interleukin-10 Science 289 2000 1352 1355
11. R.N. Fedorak, A. Gangl, C.O. Elson, P. Rutgeerts, S. Schreiber, G. Wild, S.B. Hanauer, A. Kilian, M. Cohard, A. LeBeaut, and B. Feagan Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group Gastroenterology 119 2000 1473 1482
12. J.F. Colombel, P. Rutgeerts, H. Malchow, M. Jacyna, O.H. Nielsen, J. Rask-Madsen, S. Van Deventer, A. Ferguson, P. Desreumaux, A. Forbes, K. Geboes, L. Melani, and M. Cohard Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease Gut 49 2001 42 46
13. S. Schreiber, R.N. Fedorak, O.H. Nielsen, G. Wild, C.N. Williams, S. Nikolaus, M. Jacyna, B.A. Lashner, A. Gangl, P. Rutgeerts, K. Isaacs, S.J. van Deventer, J.C. Koningsberger, M. Cohard, A. LeBeaut, and S.B. Hanauer Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group Gastroenterology 119 2000 1461 1472
14. A. Minty, P. Chalon, J.-M. Derocq, X. Dumont, J.-C. Guillemot, M. Kaghad, C. Labit, P. Leplatois, P. Liauzun, B. Miloux, C. Minty, P. Casellas, G. Loison, J. Lupker, D. Shire, P. Ferrara, and D. Caput Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses Nature 362 1993 248 250
15. G. Zurawski, and J.E. de Vries Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells Immunol. Today 15 1994 19 26
16. M. Muzio, F. Re, M. Sironi, N. Polentarutti, A. Minty, D. Caput, P. Ferrara, A. Mantovani, and F. Colotta Interleukin-13 induces the production of interleukin-1 receptor antagonist (IL-1ra) and the expression of the mRNA for the intracellular (keratinocyte) form of IL-1ra in human myelomonocytic cells Blood 83 1994 1738 1743
17. M.R. de Waal, C.G. Figdor, R. Huijbens, S. Mohan-Peterson, B. Bennett, J. Culpepper, W. Dang, G. Zurawski, and J.E. de Vries Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes: comparison with IL-4 and modulation by IFN-gamma or IL-10 J. Immunol. 151 1993 6370 6381
18. G. Radford-Smith, and D.P. Jewell Cytokines and inflammatory bowel disease Baillieres Clin. Gastroenterol. 10 1996 151 164
19. I.I. Singer, D.W. Kawka, S. Scott, J.R. Weidner, R.A. Mumford, T.E. Riehl, and W.F. Stenson Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease Gastroenterology 111 1996 871 885
20. K.A. Ribbons, X.-J. Zhang, J.H. Thompson, S.S. Greenberg, W.M. Moore, C.M. Kornmeier, M.G. Currie, N. Lerche, J. Blanchard, D.A. Clark, and M.J.S. Miller Potential role of nitric oxide in a model of chronic colitis in rhesus macaques Gastroenterology 108 1995 705 711
21. S.J. Middleton, M. Shorthouse, and J.O. Hunter Relaxation of distal colonic circular smooth muscle by nitric oxide derived from human leukocytes Gut 34 1993 814 817
22. H. Ohshima, and H. Bartsch Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis Mutat. Res. 305 1994 253 264
23. G. Kolios, Z. Brown, R.L. Robson, D.A.F. Robertson, and J. Westwick Inducible nitric oxide synthase activity and expression in a human colonic epithelial cell line, HT-29 Br. J. Pharmacol. 116 1995 2866 2872
24. G. Kolios, K.L. Wright, J.D. Linehan, D.A. Robertson, and J. Westwick Interleukin-13 inhibits nitric oxide production in human colonic mucosa Hepatogastroenterology 47 2000 714 717
25. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
26. A. Boyum Isolation of lymphocytes, granulocytes and macrophages Scand. J. Immunol. Suppl. 5 1976 9 15
27. T.P. Misko, R.J. Schilling, D. Salvemini, W.M. Moore, and M.G. Currie A fluorometric assay for the measurement of nitrite in biological samples Anal. Biochem. 214 1993 11 16
28. N.J. Jordan, G. Kolios, S.E. Abbot, M.A. Sinai, D.A. Thompson, K. Petraki, and J. Westwick Expression of functional CXCR4 chemokine receptors on human colonic epithelial cells J. Clin. Invest 104 1999 1061 1069
29. J.D. Linehan, G. Kolios, V. Valatas, D.A. Robertson, and J. Westwick Effect of corticosteroids on nitric oxide production in inflammatory bowel disease: are leukocytes the site of action? Am. J. Physiol. Gastrointest. Liver Physiol. 288 2005 G261 G267
30. S.J. Middleton, M. Shorthouse, and J.O. Hunter Increased nitric oxide synthesis in ulcerative colitis Lancet 341 1993 465 466
31. H. Kimura, R. Hokari, S. Miura, T. Shigematsu, M. Hirokawa, Y. Akiba, I. Kurose, H. Higuchi, H. Fujimori, Y. Tsuzuki, H. Serizawa, and H. Ishii Increased expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in colonic mucosa of patients with active ulcerative colitis Gut 42 1998 180 187
32. G. Kolios, V. Valatas, and S.G. Ward Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle Immunology 113 2004 427 437
33. D. Borderie, P. Hilliquin, A. Hernvann, H. Lemarechal, A. Kahan, C.J. Menkes, and O.G. Ekindjian Inhibition of inducible NO synthase by TH2 cytokines and TGF beta in rheumatoid arthritic synoviocytes: effects on nitrosothiol production Nitric Oxide 6 2002 271 282
34. E. Molina-Holgado, J.M. Vela, A. Arevalo-Martin, and C. Guaza LPS/IFN-gamma cytotoxicity in oligodendroglial cells: role of nitric oxide and protection by the anti-inflammatory cytokine IL-10 Eur. J. Neurosci. 13 2001 493 502
35. N. Berkman, A. Robichaud, R.A. Robbins, G. Roesems, E.B. Haddad, P.J. Barnes, and K.F. Chung Inhibition of inducible nitric oxide synthase expression by interleukin-4 and interleukin-13 in human lung epithelial cells Immunology 89 1996 363 367
36. K. Wright, S.G. Ward, G. Kolios, and J. Westwick Activation of phosphatidylinositol 3-kinase by interleukin-13: an inhibitory signal for inducible nitric-oxide synthase expression in epithelial cell line HT-29 J. Biol. Chem. 272 1997 12626 12633
37. M.C. Li, and S.H. He IL-10 and its related cytokines for treatment of inflammatory bowel disease World J. Gastroenterol. 10 2004 620 625
38. P.J. Ceponis, F. Botelho, C.D. Richards, and D.M. McKay Interleukins 4 and 13 increase intestinal epithelial permeability by a phosphatidylinositol 3-kinase pathway: lack of evidence for STAT 6 involvement J. Biol. Chem. 275 2000 29132 29137
39. K. Kajiwara, M. Shinazawa, H. Morishima, and Y. Yanagihara Differential effect of IL-4 and IL-13 on the expression of recombination-activating genes in mature B cells from human peripheral blood Cell. Immunol. 227 2004 121 128
40. A.C. Fluckiger, F. Briere, G. Zurawski, J.M. Bridon, and J. Banchereau IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukaemia cells Immunology 83 1994 397 403
41. F.D. Finkelman, M. Yang, C. Perkins, K. Schleifer, A. Sproles, J. Santeliz, J.A. Bernstein, M.E. Rothenberg, S.C. Morris, and M. Wills-Karp Suppressive effect of IL-4 on IL-13-induced genes in mouse lung J. Immunol. 174 2005 4630 4638
42. G. Zund, J.L. Madara, A.L. Dzus, C.S. Awtrey, and S.P. Colgan Interleukin-4 and interleukin-13 differentially regulate epithelial chloride secretion J. Biol. Chem. 271 1996 7460 7464
43. T.T. McDonald, and J.O. Spencer Gut immunology Baillieres Clin. Gastroenterol. 4 1990 291 313
44. K.W. Beagley, and A.J. Husband Intraepithelial lymphocytes: origins, distribution, and function Crit. Rev. Immunol. 18 1998 237 254
45. P.H. Hart, C.S. Bonder, J. Balogh, H.L. Dickensheets, N. Vazquez, K.V. Davies, J.J. Finlay-Jones, and R.P. Donnelly Diminished responses to IL-13 by human monocytes differentiated in vitro: role of the IL-13Ralpha1 chain and STAT6 Eur. J. Immunol. 29 1999 2087 2097
46. R. Brattsand, and M. Linden Cytokine modulation by glucocorticoids: mechanisms and actions in cellular studies Aliment. Pharmacol. Ther. 10 Suppl. 2 1996 81 90